“…The experimental conditions for the established mouse iPS cells are as follows: (1) mouse iPS cells were cultured on MEF feeder cells in mouse iPS cell medium [DMEM with 15 % Knockout Serum Replacement (referred to as KSR, #10828-028, Invitrogen), 0.22 mM 2-mercaptoethanol (#21438-82, Nacalai Tesque), 100 9 MEM Non-essential Amino Acids Solution (#139-15651, Wako Pure Chemical Industries, Osaka, Japan), 1009 antibiotic-antimycotic mixed solution and 1,0009 leukemia inhibitory factor (LIF, Human, recombinant, Culture Supernatant, #125-05603, Wako Pure Chemical Industries)]; (2) mouse iPS cells were cultured on collagen (Cellmatrix Type I-A, Nitta Gelatin, Osaka, Japan)-coated dishes in ESF-C medium (#2004-05, Cell Science and Technology Institute, Sendai, Japan) containing 1,000 9 LIF; (3) the same cell culture of point (2) containing three low-molecular-weight inhibitors [1.5 lM CHIR99021 (#163-24001, Wako Pure Chemical Industries), 0.5 lM PD0325901 (hereinafter the combination of these two inhibitors are referred to as 2i for short, #13034, Cayman Chemical, Ann Arbor, MI, USA), and 0.5 lM Thiazovivin (referred to as Tzv, #04-0017, Stemgent, Cambridge, MA, USA)]. The preparation of MEFs and feeder cells were described in our previous report (Donai et al 2013). …”